Pregled bibliografske jedinice broj: 1228539
High Prevalence of Untreated and Undertreated Vitamin D Deficiency and Insufficiency in Patients with Inflammatory Bowel Disease
High Prevalence of Untreated and Undertreated Vitamin D Deficiency and Insufficiency in Patients with Inflammatory Bowel Disease // Acta clinica Croatica, 59 (2020), 109-118 doi:10.20471/acc.2020.59.01.13 (recenziran, članak, znanstveni)
CROSBI ID: 1228539 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
High Prevalence of Untreated and Undertreated
Vitamin D Deficiency and Insufficiency in Patients
with Inflammatory Bowel Disease
Autori
Domislović, Viktor ; Vranešić Bender, Darija ; Barišić, Ana ; Brinar, Marko ; Ljubas Kelečić, Dina ; Rotim, Cecilija ; Novosel, Martin ; Matašin, Marija ; Krznarić, Željko
Izvornik
Acta clinica Croatica (0353-9466) 59
(2020);
109-118
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Inflammatory bowel diseases, Vitamin D deficiency, Crohn’s disease, Colitis, ulcerative
Sažetak
Inflammatory bowel disease (IBD) patients with vitamin D deficiency show an increased risk of hospital admission, surgery, and loss of response to biologic therapy while high vitamin D levels are identified as a protective factor. Our goal was to investigate the prevalence of untreated and undertreated vitamin D deficiency and factors associated with vitamin D deficiency. In this cross-sectional study, we measured serum vitamin D in a random sample of Caucasian IBD patients. Vitamin D deficiency was defined as <50 nmol/L and insufficiency as 50-75 nmol/L. Supplementation was defined as taking 800-2000 IU vitamin D daily. Untreated patients were defined as not taking supplementation and undertreated group as receiving supplementation but showing vitamin D deficiency or insufficiency despite treatment. Our study included 185 IBD patients, i.e. 126 (68.1%) with Crohn’s disease (CD) and 59 (31.9%) with ulcerative colitis (UC). Overall, 108 (58.4%) patients had vitamin D deficiency and 60 (32.4%) patients vitamin D insufficiency. There were 16 (14.8%) and 11 (18.3%) treated patients in vitamin D deficiency and vitamin D insufficiency group, respectively. The rate of untreated patients was 81.7% (n=49) in vitamin D deficiency group and 85.2% (n=92) in vitamin D insufficiency group. Tumor necrosis factor alpha inhibitors were associated with higher serum vitamin D levels in CD and UC, and ileal involvement, ileal and ileocolonic resection with lower levels. In conclusion, not only is vitamin D deficiency common in IBD patients but the proportion of untreated and undertreated patients is considerably high. We suggest regular monitoring of vitamin D levels in IBD patients regardless of receiving vitamin D supplementation therapy.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb
Profili:
Cecilija Rotim
(autor)
Marija Matašin
(autor)
Dina Ljubas Kelečić
(autor)
Marko Brinar
(autor)
Željko Krznarić
(autor)
Darija Vranešić Bender
(autor)
ANA BARIŠIĆ
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE